SUBSTANZEN / STEROID / DECA DURABOLIN
STEROID

DECA DURABOLIN

HIGH RISK
BEST FOR:Muscle Mass●●●●●●●●○○8/10
DECA DURABOLIN · NANDROLONE DECANOATE · 19-NORTESTOSTERONE DECANOATE · DECA · ND · DECA-DURABOLIN · NANDROLONE DECANOATE INJECTION
Anabolic SteroidAndrogenNandrolonePerformance EnhancementWADA BannedInjectable

Long-acting injectable nandrolone ester used clinically for wasting syndromes and illicitly for muscle growth.

ROUTE / DOSAGE
NIEDRIG100mg
STANDARD200-400mg
HOCH600mg+
Note: Less common than IM; risk of local tissue reaction and pseudotumor formation
ZYKLUS
1-2 injections per week 8-12 week cycles typical
BIOAVAILABILITY
~100% IM (depot injection) negligible oral
ACTIVE DURATION
3-4 weeks (subjective)
STORAGE
Room temperature (15-25°C) protect from light do not refrigerate as oil may thicken
HALBWERTSZEIT
6-12 days (plasma)
DURATION BREAKDOWN
Total3-4 weeks
Onset1-2 weeks
Come up2-3 weeks
Peak2-4 weeks
Offset3-4 weeks
After effects4-6 weeks
Duration varies by route, dose, and individual. Source: community reports.
§ 01 — WIRKUNGEN
7 dokumentiert
Significant muscle mass increase
Enhanced nitrogen retention
Improved collagen synthesis and joint comfort
Increased red blood cell production
Reduced androgenic effects vs testosterone
Progestogenic activity
Suppression of endogenous testosterone
§ 02 — RISIKEN
Severe suppression of endogenous testosterone and HPTA axis
Cardiovascular damage including hypertension and dyslipidemia
Hepatotoxicity with prolonged use
Virilization in women (hirsutism, voice deepening)
Psychiatric effects including aggression, anxiety, and sleep disorders
Infertility and hormonal disorders with chronic abuse
§ 03 — WECHSELWIRKUNGEN
Für diese Substanz liegen noch keine Wechselwirkungsdaten vor.
§ 04 — WISSENSCHAFT

Nandrolone decanoate has been studied clinically for post-traumatic recovery, cachexia, Sjögren's syndrome, and telomeropathies, with modest benefits reported in some populations. A systematic review of 148 studies found endocrine side effects (42%), cardiovascular dysfunction (14%), skin disorders (12%), and psychiatric disturbances (9%) as the most common adverse effects in illicit users. Evidence for performance enhancement is largely observational and confounded by polypharmacy. Clinical trials are small and short-term, limiting conclusions on long-term safety. The compound remains medically approved in some countries for osteoporosis and anemia but has been withdrawn in others.

§ 06 — QUELLEN
[1]
Nandrolone Decanoate: Use, Abuse and Side Effects
pubmed.ncbi.nlm.nih.gov ↗
[2]
Deca-Durabolin and cytotoxic drugs
pubmed.ncbi.nlm.nih.gov ↗
[3]
Nandrolone decanoate: new therapeutic option for telomeropathies?
pubmed.ncbi.nlm.nih.gov ↗
[4]
Nandrolone decanoate (deca-durabolin) in primary Sjögren's syndrome
pubmed.ncbi.nlm.nih.gov ↗
[5]
Deca-Durabolin and parenteral nutrition in post-traumatic patients
pubmed.ncbi.nlm.nih.gov ↗
[6]
Exuberant local tissue reaction to intramuscular injection of nandrolone decanoate
pubmed.ncbi.nlm.nih.gov ↗
Haftungsausschluss. Protokol.wiki ist ein informatives Nachschlagewerk. Nichts auf dieser Seite ist medizinischer Rat. Aufgeführte Substanzen können in deiner Rechtsordnung nicht zugelassen, unreguliert oder illegal sein. Konsultiere vor der Anwendung einen Arzt. Daten aus begutachteter Fachliteratur zusammengestellt.
METHODIKMITWIRKENKONTAKT